AzTrials
AzTrials

Hip FractureNCT02458547

Effect of Anesthesia Technique on Outcome After Hip Fracture Surgery in Elderly Adult Patients

A study testing Desflurane, Propofol and Bupivacaine in people with Hip Fracture, run by Yonsei University at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Despite many previous studies, whether anesthetic technique will significantly affect overall patient outcome, morbidity and mortality in elderly hip fracture patients is controversial. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Hip Fracture
What is being tested?
Desflurane, Propofol and Bupivacaine
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
186 participants
Where
1 siteSouth Korea
Study dates
May 2015to 21 Jan 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • 1. Patients older than 65 years scheduled for elective or emergency hip fracture surgery.

Who cannot join

  • Patient refusal
  • Inflammation or wound at puncture site, increased intracranial pressure, bleeding diathesis
  • Allergies to propofol or its ingredients, soybeans or peanuts
  • Patients with altered mental status
  • Illiterate patients or foreigners

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University Health System

    Seoul, 120-752

Other trials in South Korea

About this study

Despite many previous studies, whether anesthetic technique will significantly affect overall patient outcome, morbidity and mortality in elderly hip fracture patients is controversial. Due to old age, poor patient condition and emergent clinical settings, patients undergoing surgical procedures for hip fracture management are often subject to poor postoperative outcome and high mortality rates. While many studies have reported that regional anesthesia leads to improved postoperative outcome after hip fracture surgery, others have concluded otherwise. Moreover, because the majority of these previous studies are retrospective cohorts or systemic reviews, there is a need for randomized clinical trials to provide high quality evidence. This study aims to compare patient outcome between three different anesthetic techniques in elderly patients undergoing surgery for hip fracture management by evaluating proinflammatory cytokines, chemistry lab testing and clinical outcome between general anesthesia with either desflurane or propofol-based TIVA and spinal anesthesia with bupivacaine.

Conditions
Hip Fracture
Being tested
Desflurane, Propofol, Bupivacaine
Medical subject headings
Hip Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DesfluraneDrug

    Inhalation anesthesia with desflurane at age-adjusted MAC of 0.8~1.0

  • PropofolDrug

    Total intravenous anesthesia with propofol target controlled infusion

  • BupivacaineDrug

    Spinal anesthesia with 0.5% bupivacaine

Study groups in NCT02458547
Study groupRoleWhat they receive
Group DExperimentalGeneral anesthesia with desflurane
Receives: Drug: Desflurane
Group PActive comparatorGeneral anesthesia with propofol total intravenous anesthesia
Receives: Drug: Propofol
Group SActive comparatorSpinal anesthesia with 0.5% bupivacaine
Receives: Drug: Bupivacaine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. HMGB1

    Measured: from preoperative baseline to 72hours

  2. IL-6

    Measured: from preoperative baseline to 72hours

  3. NT-proBNP

    Measured: from preoperative baseline to 72hours

  4. hemoglobin

    Measured: from preoperative baseline to 72hours

  5. total lymphocyte count

    Measured: from preoperative baseline to 72hours

  6. albumin

    Measured: from preoperative baseline to 72hours

  7. creatinine

    Measured: from preoperative baseline to 72hours

  8. potassium

    Measured: from preoperative baseline to 72hours

  9. troponin-T

    Measured: from preoperative baseline to 72hours

  10. CRP

    Measured: from preoperative baseline to 72hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2015 (estimated)
  2. Study startMay 2015
  3. Primary completion21 Jan 2019
  4. Study completion21 Jan 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
186 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02458547
Sponsor's protocol ID
4-2015-0088
Status last verified
Mar 2019
First submitted
26 May 2015
Last updated
19 Mar 2019
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Desflurane, Propofol and Bupivacaine in people with Hip Fracture, run by Yonsei University at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

HMGB1 (time frame: from preoperative baseline to 72hours). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in